FYK-1388

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFYK-1388
Drug Alias NameFYK-1388FYK-1352
ClassificationSmall molecules
Mechanisms of ActionDisintegrin and metalloproteinase domain-containing protein 17 inhibitorsMetastasis inhibitorsMatrix metalloproteinase inhibitors
TargetsDisintegrin and metalloproteinase domain-containing protein 17Matrix metalloproteinase
Therapy Area/IndicationsArthritisNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Seiyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Seiyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsArthritisNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A